The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

Background Our previous genome-wide association study using the MA.27 aromatase inhibitors adjuvant trial identified SNPs in the long noncoding RNA MIR2052HG associated with breast cancer-free interval. MIR2052HG maintained ERα both by promoting AKT/FOXO3-mediated ESR1 transcription and by limiting...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research : BCR Vol. 21; no. 1; pp. 47 - 17
Main Authors: Cairns, Junmei, Ingle, James N., Kalari, Krishna R., Shepherd, Lois E., Kubo, Michiaki, Goetz, Matthew P., Weinshilboum, Richard M., Wang, Liewei
Format: Journal Article
Language:English
Published: London BioMed Central 03.04.2019
Springer Nature B.V
BMC
Subjects:
ISSN:1465-542X, 1465-5411, 1465-542X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first